Pharma Traders Profile
Key Indicators
- Authorised Capital ₹ 12.50 Cr
as on 07-12-2024
- Paid Up Capital ₹ 12.28 Cr
as on 07-12-2024
- Company Age 23 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 Cr
as on 07-12-2024
- Satisfied Charges ₹ 39.16 Cr
as on 07-12-2024
- Revenue 6467.87%
(FY 2022)
- Profit 821.40%
(FY 2022)
- Ebitda 1.59%
(FY 2022)
- Net Worth 50.69%
(FY 2022)
- Total Assets -22.96%
(FY 2022)
About Pharma Traders
The Corporate was formerly known as Swan Distributors Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 12.50 Cr and a paid-up capital of Rs 12.28 Cr.
The company currently has active open charges totaling ₹3.00 Cr. The company has closed loans amounting to ₹39.16 Cr, as per Ministry of Corporate Affairs (MCA) records.
Subhash Agrawal and Gulab Agrawal serve as directors at the Company.
- CIN/LLPIN
U52311MP2001PTC014504
- Company No.
014504
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pharma Traders?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhash Agrawal  | Managing Director | 03-Jan-2001 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gulab Agrawal | Director | 28-Mar-2001 | Current |
Financial Performance and Corporate Structure Insights of Pharma Traders.
Pharma Traders Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 6467.87% increase. The company also saw a substantial improvement in profitability, with a 821.4% increase in profit. The company's net worth Soared by an impressive increase of 50.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharma Traders?
In 2022, Pharma Traders had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
P-Trade Fmcg Private LimitedActive 13 years 5 monthsSubhash Agrawal and Gulab Agrawal are mutual person
- Devi Anusuiya Vidya SansthanActive 13 years 8 months
Subhash Agrawal and Gulab Agrawal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Au Financiers (India) Limited Creation Date: 09 Feb 2015 | ₹3.00 Cr | Open |
Intec Capital Limited Creation Date: 31 Oct 2013 | ₹1.19 Cr | Satisfied |
State Bank Of India Creation Date: 20 Aug 2013 | ₹3.40 Cr | Satisfied |
How Many Employees Work at Pharma Traders?
Pharma Traders has a workforce of 2 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharma Traders, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharma Traders's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
